AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

STRATEC SE

Director's Dealing Oct 5, 2018

416_dirs_2018-10-05_d61c9b37-f1ff-41d4-a448-4facf4772a3a.html

Director's Dealing

Open in Viewer

Opens in native device viewer

News Details

Directors’ Dealings | 5 October 2018 10:49

DGAP-DD: STRATEC Biomedical AG english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

05.10.2018 / 10:48

The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title: Dr.
First name: Robert
Last name(s): Siegle

2. Reason for the notification

a) Position / status

Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

STRATEC Biomedical AG

b) LEI

529900ZZJWANAFSPGV30

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type: Share
ISIN: DE000STRA555

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s) Volume(s)
46.30 EUR 7315.40 EUR
46.40 EUR 2366.40 EUR
46.45 EUR 3251.50 EUR
46.50 EUR 91651.50 EUR

d) Aggregated information

Price Aggregated volume
46.4821333 EUR 104584.80 EUR

e) Date of the transaction

2018-10-05; UTC+2

f) Place of the transaction

Name: XETRA
MIC: XETA

05.10.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com
End of News DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.